Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic

詳細情報 詳細情報について

• CRID

  1360579816599986944

• DOI

  10.1186/s13046-016-0456-2

• ISSN

  17569966

• Web Site

  http://link.springer.com/content/pdf/10.1186/s13046-016-0456-2.pdf

• データソース種別

  • Crossref